Back to Insider Trading View Full Company Profile

BBNX

UNKNOWN

Beta Bionics, Inc.

CIK: 0001674632

Strong Sell (90% confidence)

Last activity: 4 weeks ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Total Cash $31.58M

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
Feider Stephen
Chief Financial Officer
0 2 -$608K
172,729 shares
$2.14M
Mensinger Mike
Chief Product Officer
0 4 -$310K
188,793 shares
$2.33M
Hopman Mark
Chief Commercial Officer
0 3 -$78K
139,133 shares
$1.61M
Saint Sean
President & CEO
0 1 -$42K
437,809 shares
$5.41M
Russell Steven Jon
Chief Medical Officer
0 1 -$13K
179,096 shares
$2.21M

Recent Transactions

SELL Hopman Mark (Chief Commercial Officer)

353 shares @ $11.57

$4K

Mar 4, 2026

Conviction: | View SEC Filing →
SELL Saint Sean (President & CEO)

3,384 shares @ $12.36

$42K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Feider Stephen (Chief Financial Officer)

1,428 shares @ $12.36

$18K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Mensinger Mike (Chief Product Officer)

1,064 shares @ $12.36

$13K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Russell Steven Jon (Chief Medical Officer)

1,026 shares @ $12.36

$13K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Hopman Mark (Chief Commercial Officer)

834 shares @ $12.36

$10K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Mensinger Mike (Chief Product Officer)

2,200 shares @ $30.10

$66K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Feider Stephen (Chief Financial Officer)

20,000 shares @ $29.53

$591K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Mensinger Mike (Chief Product Officer)

7,200 shares @ $29.56

$213K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Mensinger Mike (Chief Product Officer)

600 shares @ $30.20

$18K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Hopman Mark (Chief Commercial Officer)

2,061 shares @ $30.66

$63K

Dec 4, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.